G67E (p.Gly67Glu) variant of TNXB (Tenascin-X)

Name: TNXB G67E (p.Gly67Glu) variant | CATVariant
Creator: Center for Precision Medicine and Data Sciences
Published: 2026-10-09
License: https://catvariant.com/terms-of-use

G67E (p.Gly67Glu) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes structural context.

G67E (p.Gly67Glu) variant details

p.Gly67Glu
NCI-TCGA Cosmic COSV6447
cosmic curated COSV64476
Variant assessed as somatic; moderate impact.
Missense
Variant Prioritization Score for Impact Estimate 0.353
ESM-1b 0.13
AlphaMissense 0.34
UniProt: Variant assessed as somatic; moderate impact.
Structural context available